1. Home
  2. LINC vs IVVD Comparison

LINC vs IVVD Comparison

Compare LINC & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lincoln Educational Services Corporation

LINC

Lincoln Educational Services Corporation

HOLD

Current Price

$24.85

Market Cap

732.0M

Sector

Real Estate

ML Signal

HOLD

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$2.61

Market Cap

692.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LINC
IVVD
Founded
1946
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
732.0M
692.7M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
LINC
IVVD
Price
$24.85
$2.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$26.67
$8.75
AVG Volume (30 Days)
191.3K
5.2M
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
40.12
N/A
EPS
0.45
N/A
Revenue
$494,742,000.00
$50,039,000.00
Revenue This Year
$17.79
$103.88
Revenue Next Year
$9.33
$171.40
P/E Ratio
$55.40
N/A
Revenue Growth
16.90
332.71
52 Week Low
$14.10
$0.35
52 Week High
$25.76
$3.07

Technical Indicators

Market Signals
Indicator
LINC
IVVD
Relative Strength Index (RSI) 70.18 56.55
Support Level $23.00 $2.52
Resistance Level $25.07 $2.85
Average True Range (ATR) 0.70 0.21
MACD 0.19 0.02
Stochastic Oscillator 90.59 50.60

Price Performance

Historical Comparison
LINC
IVVD

About LINC Lincoln Educational Services Corporation

Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services, and business and information technology. Its reportable segments include; Campus Operations, and Transitional. The majority of the revenue is generated from the Campus Operations segment which includes all campuses that are continuing in operation and contribute to the Company's core operations and performance.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: